REGENERON PHARMACEUTICALS, INC. (REGN)

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Address

777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591

Founded

1988

Number of Employees

13,450

Website

http://www.regeneron.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s )		 - $8,308 $2,021 $100,068 $1,031 $357,178 $5,883,852 $1,719,452 $2,181,647 $2,622,549 $914,223 $1,379,033
Average Price - $515.85 $391.74 $386.99 $393.57 $347.55 $504.30 $546.43 $635.58 $768.07 $963.63 $576.52
# Shares Purchased - 16,105 5,159 258,582 2,620 1,027,696 11,667,452 3,146,710 3,432,509 3,414,470 948,728 2,392,003
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date - 123.5% 194.3% 197.9% 193.0% 231.7% 128.6% 111.0% 81.4% 50.1% 19.7% 100.0%
S&P 500 Return to Date - 173.0% 168.6% 129.7% 104.9% 93.1% 74.8% 31.7% 37.3% 31.3% 7.4% 85.2%
Excess Total Return - -49.5% 25.7% 68.2% 88.1% 138.6% 53.8% 79.4% 44.1% 18.8% 12.2% 14.8%
Quartile Rank
Percentile Rank - 64% 76% 82% 87% 90% 80% 92% 89% 84% 77% 84%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
ALNYLAM PHARMACEUTICALS INC

Regulus Therapeutics Inc.
GILEAD SCIENCES, INC.
MCCOURT MARION

REGENERON PHARMACEUTICALS, INC.
BIOGEN INC.